Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia | Zendy

Hertzel C. Gerstein | Zendy; Guillaume Paré | Zendy; Matthew McQueen | Zendy; Heinz Haenel | Zendy; Shun Fu Lee | Zendy; Janice Pogue | Zendy; Aldo P. Maggioni | Zendy; Salim Yusuf | Zendy; Sibylle Hess | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia

Author(s) -

Hertzel C. Gerstein,

Guillaume Paré,

Matthew McQueen,

Heinz Haenel,

Shun Fu Lee,

Janice Pogue,

Aldo P. Maggioni,

Salim Yusuf,

Sibylle Hess

Publication year - 2015

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.115.015744

Subject(s) - medicine , proportional hazards model , hazard ratio , myocardial infarction , biomarker , cause of death , stroke (engine) , clinical trial , confidence interval , disease , mechanical engineering , biochemistry , chemistry , engineering

Serum biomarkers may identify people at risk for cardiovascular (CV) outcomes. Biobanked serum samples from 8494 participants with dysglycemia in the completed Outcome Reduction With Initial Glargine Intervention trial were assayed for 284 biomarkers to identify those that could identify people at risk for a CV outcome or death when added to clinical measurements.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research